Open Science Bar: Investigating microvascular alterations effect on radiotherapy joining in silico, in-vitro, and clinical data
Open Science Bar: Investigating microvascular alterations effect on radiotherapy joining in silico, in-vitro, and clinical data
Dr Alessandro Cicchetti and Luca Possenti present the results of the AIRC project “Mechanistic computational modelling o... Read more
25 Jul 2023
•
6mins
Tumori Journal - Open Science Bar: A deadly kiss to Lung Cancer Cells: dosage of KiSS1 and its biological significance
Tumori Journal - Open Science Bar: A deadly kiss to Lung Cancer Cells: dosage of KiSS1 and its biological significance
Blurb In this posdcast Dr. Luigi Rolli, Dr. Chiara Ciniselli, Dr. Paola Perego and Dr. Giulia Bertolini discuss the biol... Read more
13 Jul 2023
•
5mins
IMJ June 2023: Discussion of A New Anxiety Screening Tool with Dr Sean Kandel
IMJ June 2023: Discussion of A New Anxiety Screening Tool with Dr Sean Kandel
Dr. Sean Kandel is from the University of Nevada, Reno School of Medicine where he is an Assistant Professor of Medicine... Read more
5 Jul 2023
•
16mins
Foregut: Disparities in Benign and Malignant Foregut Disease
Foregut: Disparities in Benign and Malignant Foregut Disease
In this episode, Dr. Virginia Litle, guest editor of Foregut’s special disparities issue, talks with Dr. Malhar Parikh ... Read more
28 Jun 2023
•
33mins
Most Popular Podcasts
The Joe Rogan Experience
TED Talks Daily
The Tim Ferriss Show
The Daily
Stuff You Should Know
Oprah's SuperSoul Conversations
Armchair Expert with Dax Shepard
Tumori Journal - Author's Insight: New perspectives: glioma in adult patients
Tumori Journal - Author's Insight: New perspectives: glioma in adult patients
In this episode, Dr Antonio Silvani presents his editorial “New perspectives: glioma in adult patients”. The aim of this... Read more
21 Jun 2023
•
9mins
Tumori Journal – Author's Insight: A phase 2 study of cabozantinib for advanced renal cell carcinoma after immune-checkpoint inhibitors: the BREAKPOINT trial
Tumori Journal – Author's Insight: A phase 2 study of cabozantinib for advanced renal cell carcinoma after immune-checkpoint inhibitors: the BREAKPOINT trial
In this podcast, Dr Mélanie Claps and Dr Giuseppe Procopio discuss about the results of the Breakpoint Trial: a prospect... Read more
16 Jun 2023
•
9mins
IMJ: Lobbying Experiences at Capitol Hill with Dr. Samrat Das
IMJ: Lobbying Experiences at Capitol Hill with Dr. Samrat Das
The Journal of Investigative Medicine’s Editor in Chief Dr. McCallum welcomes Dr. Samrat Das in this episode. Dr. Das is... Read more
14 Jun 2023
•
22mins
Tumori Journal - Open Science Bar: INTperKids: An institutional opportunity for our pediatric and adolescent patients
Tumori Journal - Open Science Bar: INTperKids: An institutional opportunity for our pediatric and adolescent patients
In this podcast, Dr Michela Casanova, Dr. Patrizia Gasparini and Dr. Luca Bergamaschi discuss the importance of a pediat... Read more
24 May 2023
•
8mins
FACE: Three-Dimensional Printing for Craniomaxillofacial Surgery: A Systematic Review and Meta-analysis of Applications and Logistical Outcomes
FACE: Three-Dimensional Printing for Craniomaxillofacial Surgery: A Systematic Review and Meta-analysis of Applications and Logistical Outcomes
In this episode, co-authors Robin Yang and Matthew Heron discuss the evidence for using 3D printing in craniomaxillofaci... Read more
22 May 2023
•
34mins
Tumori Journal – Open Science Bar: A randomised trial for evaluating dietary and manual treatment with osteopathic techniques on quality of life of patients with breast cancer undergoing antiestrogenic hormonal treatment
Tumori Journal – Open Science Bar: A randomised trial for evaluating dietary and manual treatment with osteopathic techniques on quality of life of patients with breast cancer undergoing antiestrogenic hormonal treatment
In this podcast, Dr Cristina Ferraris (principal investigator) and Dr Chiara Listorti (speaker) present the SECCO Study,... Read more
3 May 2023
•
8mins
